Hoth Therapeutics, INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
Hoth Therapeutics, Inc. has filed definitive additional proxy materials for its 2025 Annual Meeting of Shareholders, seeking votes on the election of directors, ratification of its accounting firm, and an increase in shares reserved for its equity incentive plan.
NASDAQ
Hoth Therapeutics, Inc. announced its 2025 Annual Meeting of Shareholders to be held virtually on August 5, 2025, where key proposals include the election of directors, ratification of auditors, and a significant increase in shares reserved for its equity incentive plan.
NASDAQ
Hoth Therapeutics, Inc. has filed a definitive proxy statement with the Securities and Exchange Commission.
NASDAQ
Hoth Therapeutics is holding its annual shareholder meeting on August 7, 2024, to vote on director elections, ratify the appointment of its accounting firm, and approve an amendment to its equity incentive plan.